Acetazolamide for sleep apnea in people on opioid treatment
Treatments studied
Part of Mental health clinical trials.
This trial tests if a drug called acetazolamide can help people with central sleep apnea who are also on medication for opioid use disorder. Sleep apnea causes breathing to stop during sleep, and this study aims to see if the drug improves their sleep breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be on medication for opioid use disorder, like methadone or buprenorphine.
- You have been diagnosed with central sleep apnea.
- Your sleep apnea is not caused by a condition other than opioid use.
- You do not have a breathing problem called sleep-related hypoventilation.
- You are not pregnant.
- You do not have any medical reason that makes acetazolamide unsafe for you.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medicine called acetazolamide to see if it can improve how your brain controls breathing during sleep apnea. If you have sleep apnea and are not using treatment, you might be able to join.
This trial studies a treatment approach for sleep-disordered breathing (breathing problems during sleep) in Veterans who take prescription opioids. It may help doctors learn safer ways to manage sleep breathing issues that can be made worse by opioid use.
This study tests acetazolamide (a medicine that changes breathing chemistry) to see how it affects sleep quality and neurocognitive (brain/memory/attention) outcomes in adults with untreated moderate to severe sleep apnea. You may be eligible if you have significant sleep apnea but do not have certain safety risks or need to start standard sleep apnea treatment right away.
This trial studies a “rescue” set of medicines for obstructive sleep apnea when two common treatments haven’t worked well enough. If you still have frequent breathing pauses during sleep, the study may test whether these medicines can reduce them and improve safety and symptoms.
This study tests how a single dose of morphine affects breathing during sleep in healthy people and those with sleep apnea. It aims to understand the risks of opioids for people with breathing disorders.
This Phase 4 study looks at what’s going on in the body during central sleep apnea and uses that information to guide treatment. If you have central sleep apnea, this could help confirm or improve how treatment is chosen for you.
Hear when a new Central Sleep Apnea Comorbid With Opioid Use trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.